About CMBN
The Centre for Molecular Biology and Neuroscience (CMBN) at the University of Oslo and Rikshospitalet-Radiumhospitalet HF is a Norwegian Centre of Excellence, appointed by the Research Council of Norway.
Objectives
The Centre shall take on a leading role in elucidating the role of DNA repair and genome maintenance mechanisms in preventing neurological disease and brain ageing. The Centre will develop and apply stem cell technology and targeted repair to broaden the range of therapeutic strategies in neurological disease.
Management
The Centre is led by Director Prof. Ole Petter Ottersen and Assistant Director Prof. Tone Tønjum.
The board
The members of the board of CMBN are:
- Professor Ole M. Sejersted, University of Oslo (Chairman)
- Director Professor Olli A. Jänne, Biomedicum Helsinki, Finland
- Director Per Morten Vigtel, Norsk Investorforum
- Senior Adviser Inger Nina Farstad, Rikshospitalet-Radiumhospitalet
- Head of Department Peter Gaustad, Rikshospitalet-Radiumhospitalet
- Professor Borghild Roald, University of Oslo
Research groups
The Centre consists of 11 research groups at the University of Oslo (UiO) and Rikshospitalet-Radiumhospitalet Medical Centre. In total, more than 180 people are involved in the research at CMBN.
Funding
The Centre and the research groups of the Centre receive the major funding from the following organisations:
- The Research Council of Norway
- University of Oslo
- Rikshospitalet-Radiumhospitalet HF
- Norwegian Cancer Society
- European Union
Annual reports
More information
- A booklet about CMBN is available. Contact the administration for a printed copy.
- Fact sheet about CMBN from the Research Council of Norway
PO Box 1105 Blindern, NO-0317 Oslo, Norway. Tel: +47 22851528. Fax: +47 22851488